ATRIUM THERAPEUTICS INC (RNA:NASDAQ)
$8.4 0.08 (0.9615%)
Analysed ATRIUM THERAPEUTICS INC (RNA:NASDAQ) News Sources
Can Atrium Therapeutics (RNA)’s $15 Million Milestone From Bristol-Myers Squibb (BMY) Validate its RNA Platform?
28-08-2026
yahoo.com
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21-04-2026
yahoo.com
Here's Why We're Not Too Worried About Atrium Therapeutics' (NASDAQ:RNA) Cash Burn Situation
28-05-2026
yahoo.com
Atrium Therapeutics Reports Second Quarter 2026 Financial Results
13-08-2026
yahoo.com
Atrium Therapeutics to Participate in Upcoming Investor Conferences
02-09-2026
yahoo.com
Wall Street Money Is Leaving Just As Atrium’s (RNA) Pipeline Turns Real
06-09-2026
yahoo.com
Atrium Therapeutics Announces $50 Million Private Placement
08-10-2026
yahoo.com
Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing
20-10-2026
yahoo.com
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
20-10-2026
yahoo.com
Atrium Therapeutics Doses First Patient in Corventis™, the First Interventional Clinical Trial for People Living with PRKAG2 Syndrome
27-10-2026
yahoo.com
What is the current price of ATRIUM THERAPEUTICS INC (RNA:NASDAQ)?
The current price of ATRIUM THERAPEUTICS INC (RNA:NASDAQ) is $8.4.
ATRIUM THERAPEUTICS INC (RNA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ATRIUM THERAPEUTICS INC (RNA:NASDAQ) since the previous trading day is $0.08.
ATRIUM THERAPEUTICS INC (RNA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ATRIUM THERAPEUTICS INC (RNA:NASDAQ) since the previous trading day is 0.9615%.
What is the most recent average sentiment score for ATRIUM THERAPEUTICS INC (RNA:NASDAQ)?
The most recent average sentiment score for ATRIUM THERAPEUTICS INC (RNA:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for ATRIUM THERAPEUTICS INC (RNA:NASDAQ)?
The most recent sentiment for ATRIUM THERAPEUTICS INC (RNA:NASDAQ) is .
SEC-8K** Filing Available For ATRIUM THERAPEUTICS INC (RNA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.